The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients
- Conditions
- IndigestionMoralityOrgan Failure, MultipleDelayed Gastric EmptyingRespiratory Failure
- Interventions
- Other: Routine ICU careOther: historical Routine ICU careOther: traditional Chinese medicine
- Registration Number
- NCT06452966
- Lead Sponsor
- China Medical University Hospital
- Brief Summary
Critically ill patients are at risk of or suffering from one or more key organs or organ system failure. This study will measure the effect of traditional Chinese medicine(TCM) interventions on critically ill patients admitted to the intensive care unit (ICU).
The goal of this clinical trial is to learn if traditional Chinese medicine(TCM) is effective for prevention and treatment of organ failure in ICU patients. Patients in this group will receive intervention for 2 weeks.
A multi-center non-randomized real word data study, will include 3 groups: intervention group (TCM)(n=70), control group and historical control group (admitted to the same ICU in the period of 01.2019 to 12.2023).
Main outcomes include sequential organ failure assessment (SOFA) score, ICU length of stay, hospital length of stay, number of days of respirator uses and western medicine medication used study follow up will be 2 weeks.
- Detailed Description
Critically ill patients are at risk of or suffering from one or more key organs or organ system failure. This study will measure the effect of traditional Chinese medicine(TCM) interventions on critically ill patients admitted to the intensive care unit (ICU).
A multi center non-randomized real word data study, will include 3 groups: intervention group (n=70), control group (patients recruited enrolled to the ICU during the study period) and historical control group (admitted to the same ICU in the period of 01.2019 to 12.2023). The intervention group will receive traditional Chinese herbal medicine and/or acupuncture and/or low level laser applied on acupuncture points depending on TCM doctor decision and patient TCM diagnosis. Intervention period will be 2 weeks.
Main outcomes include sequential organ failure assessment (SOFA) score, ICU length of stay, hospital length of stay, number of days of respirator uses and western medicine medication used study follow up will be 2 weeks.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 350
- Age 20 and above
- Surgical ICU patients
- The use of Chinese medicine must be approved by the attending physician in the surgical intensive care unit
Exclusion criteria:
- Patients' family members refuse TCM intervention
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description control group Routine ICU care the patients in this group will receive routine ICU care. the patients will be recruted during the study period. the patients will not recive TCM intervantions. Historical control historical Routine ICU care Patients admitted to the same ICU in the period of 01.2019 to 12.2023. the patients did not recivied TCM intervantions intervention group traditional Chinese medicine patients in the group will recived one of or a combination of the following intervantions: 1. Oral Chinese medicine decoction: The Chinese medicine practitioner will personally examine the patient and judge the patient's condition through the four diagnostic methods of traditional Chinese medicine(TCM): sight, smell, inquiry, and incision. Based on the syndrome differentiation and treatment of the patient's condition, he or she will prescribe an oral Chinese herbal decoction, two to three times a day, for two weeks. 2. Acupuncture or low level laser acupuncture treatment: Chinese medicine practitioners select acupuncture points for treatment based on the patient's condition and treat them twice a week for 20 minutes each time for a total of two weeks. the intervantion depents on the TCM doctor decision based on the patient's diagnosis and needs. in addition, the patients will recive ICU care and medication based on patient's needs.
- Primary Outcome Measures
Name Time Method hospital length of stay "through study completion, an average of 3 months". The number of days a patient stays in the hospital
Intensive care unit length of stay "through study completion, an average of 3 months". the number of days a patient stays in the Intensive care unit
Patient survival and mortality "through study completion, an average of 1 year". Measure ICU, RCC, and hospital mortality
Mechanical ventilation time "through study completion, an average of 3 months". The number of days a patient requires mechanical ventilation
Respiratory care center stay "through study completion, an average of 3 months". The number of days a patient stays in the respiratory care center
- Secondary Outcome Measures
Name Time Method PaO2 rate baseline, day 1-14 of the study patients PaO2 rate in ventilator
Kidney function baseline, day 1-14 of the study Measured by blood urea nitrogen (BUN)
Number of days to reach 100% of target energy expenditure. baseline, day 1-14 of the study Daily intake Number of days out of the first 14 days the patients reach100% of target energy expenditure.
Inspiratory airflow (V') baseline, day 1-14 of the study Inspiratory airflow (V') in ventilator
Albumin baseline, day 1-14 of the study Albumin levels in blood sample
total protein baseline, day 1-14 of the study total protein levels in blood sample
Creatinine (creatinine) baseline, day 1-14 of the study Creatinine (creatinine) levels in blood sample
Daily urine output baseline, day 1-14 of the study Daily urine output in ml
Number of days out of the first 14 days the patients reach 70% of their target energy expenditure. baseline, day 1-14 of the study Daily intake Number of days out of the first 14 days the patients reach 70% of their target energy expenditure.
Oxygenation index baseline, day 1-14 of the study FiO2 rate in ventilator
Number of days to reach 80% of target energy expenditure. baseline, day 1-14 of the study Daily intake, number of days out of the first 14 days the patients reach 80% of target energy expenditure.
Respiratory rate (RR) baseline, day 1-14 of the study Respiratory rate (RR) in ventilator
Respirator parameters baseline, day 1-14 of the study Tidal volume (VT) in ventilator
Positive end-expiratory pressure (PEEP) baseline, day 1-14 of the study Positive end-expiratory pressure (PEEP) in ventilator
Alanine transaminase (ALT) baseline, day 1-14 of the study Alanine transaminase (ALT) levels in blood sample
Liver function baseline, day 1-14 of the study Aspartate transaminase (AST) levels in blood sample
Alkaline phosphatase (ALP), baseline, day 1-14 of the study Alkaline phosphatase (ALP), levels in blood sample
Bilirubin, baseline, day 1-14 of the study Bilirubin, levels in blood sample
L-lactate dehydrogenase (LD) baseline, day 1-14 of the study L-lactate dehydrogenase (LD) levels in blood sample
use of vasopressors. baseline, day 1-14 of the study Measured by use of vasopressors.
Prothrombin time (PT) baseline, day 1-14 of the study Prothrombin time (PT)
Cardiovascular function baseline, day 1-14 of the study Measured by blood pressure
Glasgow Coma Scale (GCS) baseline, day 1-14 of the study Glasgow Coma Scale (GCS)
Trial Locations
- Locations (1)
China Medical University Hospital
🇨🇳Taichung, Taiwan